Table 5.
Gene | Isolate n=95 (%) | NO. (%) of Antibiotic resistance | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||
CX | CTR | CTX | CAZ | FEP | AUG | A/S | PI | PIT | AT | IMI | MRP | CL | GEN | AK | CIP | ||
bla SHV-2a | 21 (22.1) | 19 (90) | 4 (19) | 5 (23) | 21 (100) | 9 (42) | 16 (76) | 21 (100) | 3 (14) | 0 | 11 (52) | 0 | 0 | 3 (14) | 0 | 0 | 1 (4%) |
PER | 1 (1.05) | 1 (100) | 0 | 1 (100) | 1 (100) | 0 | 0 | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 | 1 (100) | 1 (100) | 1 (100%) |
SHV + PER | 1 (1.05) | 1 (100) | 1 (100) | 0 | 1 (100) | 0 | 1 (100) | 1 (100) | 0 | 0 | 1 (100) | 0 | 0 | 0 | 0 | 1 (100) | 1 (100) |
SHV + VEB | 2 (2.1) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 1 (50) | 2 (100) | 2 (100) | 1 (50) | 0 | 1 (50) | 0 | 0 | 0 | 0 | 0 | 1 (50) |
PER + VEB | 1 (1.05) | 1 (100) | 1 (100) | 0 | 1 (100) | 0 | 0 | 1 (100) | 1 (100) | 1 (100) | 0 | 1 (100) | 1 (100) | 0 | 1 (100) | 1 (100) | 1 (100) |
SHV + PER + VEB | 1 (1.05) | 1 (100) | 1 (100) | 0 | 1 (100) | 0 | 1 (100) | 1 (100) | 0 | 0 | 1 (100) | 0 | 0 | 0 | 0 | 0 | 0 |
bla CTX-M-28 | 1 (1.05) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | a0 | 1 (100) | 1 (100) | 1 (100) |
bla OXA-677 | 39 (41.05) | 39 (100) | 38 (97) | 39 (100) | 39 (100) | 37 (94) | 38 (97) | 39 (100) | 38 (97) | 39 (100) | 39 (100) | 39 (100) | 39 (100) | 1 (2) | 39 (100) | 39 (100) | 39 (100) |
OXA-677 + CTX-M-28 | 17 (17.89) | 17 (100) | 16 (94) | 17 (100) | 17 (100) | 15 (88) | 15 (88) | 17 (100) | 17 (100) | 17 (100) | 17 (100) | 17 (100) | 17 (100) | 2 (11) | 17 (100) | 17 (100) | 17 (100) |
P value | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 |